A carregar...
THE ASPREE STUDY: DEMENTIA DUE TO ALZHEIMER’S DISEASE OUTCOMES
In the ASPREE clinical trial, aspirin 100mg daily in health older adults did not delay onset of dementia, a pre-specified secondary outcome over a period of 5 years. We examine whether low-dose aspirin versus placebo is related to incident dementia due to Alzheimer’s disease. Older community-dwellin...
Na minha lista:
| Publicado no: | Innov Aging |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6841487/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/geroni/igz038.2359 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|